Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 3
2009 2
2010 1
2011 1
2012 2
2013 2
2014 2
2015 1
2016 2
2017 5
2018 4
2019 7
2020 4
2021 3
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Potential Role of CHI3L1+ Astrocytes in Progression in MS.
Cubas-Núñez L, Gil-Perotín S, Castillo-Villalba J, López V, Solís Tarazona L, Gasqué-Rubio R, Carratalá-Boscá S, Alcalá-Vicente C, Pérez-Miralles F, Lassmann H, Casanova B. Cubas-Núñez L, et al. Among authors: gil perotin s. Neurol Neuroimmunol Neuroinflamm. 2021 Mar 3;8(3):e972. doi: 10.1212/NXI.0000000000000972. Print 2021 May 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33658322 Free PMC article.
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
Alcalá C, Quintanilla-Bordás C, Gascón F, Sempere ÁP, Navarro L, Carcelén-Gadea M, Landete L, Mallada J, Cañizares E, Belenguer A, Carratalá S, Domínguez JA, Pérez-Miralles FC, Gil-Perotín S, Gasqué R, Cubas L, Castillo J, Casanova B. Alcalá C, et al. Among authors: gil perotin s. J Neurol. 2022 Jul;269(7):3676-3681. doi: 10.1007/s00415-022-10989-0. Epub 2022 Feb 2. J Neurol. 2022. PMID: 35107597
CSF chitinase 3-like-1 association with disability of primary progressive MS.
Pérez-Miralles F, Prefasi D, García-Merino A, Gascón-Giménez F, Medrano N, Castillo-Villalba J, Cubas L, Alcalá C, Gil-Perotín S, Gómez-Ballesteros R, Maurino J, Álvarez-García E, Casanova B. Pérez-Miralles F, et al. Among authors: gil perotin s. Neurol Neuroimmunol Neuroinflamm. 2020 Jul 1;7(5):e815. doi: 10.1212/NXI.0000000000000815. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32611760 Free PMC article.
42 results